NeoImmuneTech, Inc. (950220) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NeoImmuneTech, Inc. (950220:KRX), powered by AI.
- Current Price
- ₩548
- P/E Ratio
- -0.3
- Market Cap
- 54.2B
- Sector
- Healthcare
What is the NeoImmuneTech, Inc. stock price forecast?
NeoImmuneTech, Inc. is currently trading at ₩548. View real-time AI analysis on Alpha Lenz.
What is NeoImmuneTech, Inc. insider trading activity?
View the latest insider trading data for NeoImmuneTech, Inc. on Alpha Lenz.
What is NeoImmuneTech, Inc.'s P/E ratio?
NeoImmuneTech, Inc.'s P/E ratio is -0.3.
NeoImmuneTech, Inc.
KRX · 950220“NeoImmuneTech, Inc. trades at a P/E of -0.3 (undervalued) with modest ROE of -70.2%.”
Ask for details →Company Overview
NeoImmuneTech, Inc. is a biotechnology company focused on developing innovative immunotherapeutic solutions for cancer treatment. At the forefront of their product line is a novel portfolio of products designed to enhance the immune system's ability to target and destroy cancer cells. A key feature of NeoImmuneTech's research and development approach involves the use of long-acting IL-7, a cytokine critical for T-cell proliferation, to improve immune responses in cancer patients. The company operates within the healthcare sector, impacting the oncology and broader biopharmaceutical industries with its cutting-edge research. NeoImmuneTech is strategically positioned to influence cancer treatment paradigms through proprietary technologies that aim to expand the immune system's capacity and resilience. By striving to offer safer, more effective cancer therapies, NeoImmuneTech plays a significant role in the ongoing transformation of personalized medicine, contributing to advancements that may set the stage for future breakthroughs in cancer care.
Company Statistics
FY 2024Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“NeoImmuneTech, Inc. trades at a P/E of -0.3 (undervalued) with modest ROE of -70.2%.”
Ask for details →Frequently Asked Questions
NeoImmuneTech, Inc. (ticker: 950220) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 52 employees. Market cap is $54.2B.
The current price is ₩548 with a P/E ratio of -0.26x and P/B of 0.26x.
ROE is -70.17% and operating margin is -23497.60%. Annual revenue is $170M.